Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 12, 2025Frontiers in EndocrinologyOpen Access

A glimpse into the pipeline of anti-obesity medication development: combining multiple receptor pathways

View Full Paper
Ask AI
Bookmark
Share

Authors

CPChristine ParkYKYushin KimSRSawye Raygani

Discussion

Loading...

Member takes

Overview

This review highlights emerging agents for obesity treatment, suggesting improved efficacy through combination strategies.

Key Points

  • Recent advances in anti-obesity pharmacotherapy offer hope for patients living with obesity, improving treatment efficacy.
  • Obesity, a chronic metabolic disease, has seen an influx of emerging agents that show promise in addressing underlying causes.
  • The review discusses how combination strategies between different receptor pathways may enhance the effectiveness of obesity treatment.
  • Despite the effectiveness of metabolic bariatric surgery, anti-obesity medications represent a less invasive option worth exploring.

Cite This Study

Park et al. (2025) studied this question.

synapsesocial.com/papers/68d44b3f31b076d99fa54ff0https://doi.org/10.3389/fendo.2025.1630199
View Full Paper
Ask AI
Bookmark
Share